Preclinical Studies of OBI-999: A Novel Globo H-Targeting Antibody-Drug Conjugate

Yang, MC; Shia, CS; Li, WF; Wang, CC; Chen, IJ; Huang, TY; Chen, YJ; Chang, HW; Lu, CH; Wu, YC; Wang, NH; Lai, JS; Yu, CD; Lai, MT

Lai, MT (corresponding author), OBI Pharma Inc, 7F,369 Zhongxiao E Rd, Taipei 115, Taiwan.

MOLECULAR CANCER THERAPEUTICS, 2021; 20 (6): 1121

Abstract

Globo H (GH), a hexasaccharide, is expressed at low levels in normal tissues but is highly expressed in multiple cancer types, rendering it a promisin......

Full Text Link